Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients.

Hegazy, Sahar K; Tharwat, Samar; Hassan, Ahmed H

Hegazy, Sahar K; Tharwat, Samar; Hassan, Ahmed H.

Afiliación

Hegazy SK; Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, PC: 31511, Egypt.
Tharwat S; Rheumatology and Immunology Department, Faculty of Medicine, Mansoura University, Mansoura, PC: 35511, Egypt.
Hassan AH; Clinical pharmacy Department, Mansoura University Hospital, Mansoura, PC: 35511, Egypt.

Open Med (Wars) ; 18(1): 20230768, 2023.

Article en En | MEDLINE | ID: mdl-37588660

Palabras clave

COVID-19; antivirals; casirivimab and imdevimab; favipiravir; remdesivir

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Ethics Idioma: En Revista: Open Med (Wars) Año: 2023 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google